Zufaa-MR 4 Tablet is a combination medication containing Paracetamol 500 mg and Thiocolchicoside 4 mg, formulated for the management of musculoskeletal pain and associated inflammation. Paracetamol acts as an analgesic and antipyretic, providing effective relief from mild to moderate pain and reducing fever through inhibition of prostaglandin synthesis in the central nervous system. Thiocolchicoside, a muscle relaxant with anti-inflammatory properties, acts by selectively binding to GABA and glycine receptors, thereby reducing muscle spasms and improving mobility in conditions characterized by muscle stiffness and spasticity. This dual-action tablet is commonly prescribed for acute musculoskeletal disorders such as strains, sprains, low back pain, and other painful muscle conditions. Zufaa-MR 4 Tablet offers symptomatic relief by addressing both pain and muscle spasm simultaneously, enhancing patient comfort and facilitating faster recovery. It is recommended to be taken orally as directed by a healthcare professional, with caution advised in patients with liver impairment, hypersensitivity to any component, or pre-existing gastrointestinal conditions. Use during pregnancy and lactation should be under medical supervision. Adverse effects are generally mild but may include gastrointestinal discomfort, dizziness, or allergic reactions. Patients should adhere strictly to prescribed dosages to minimize risk of toxicity.